Find a Clinical Trial
Filter
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
Home Cooking Patterns and IBD
Inflammatory bowel disease
All genders
18-89
Recruiting now
Department of Medicine, Division of Gastroenterology + Hepatology
The Mucosal Metagenome of Ulcerative Colitis in Remission
Inflammatory bowel disease
All genders
18-75
Recruiting now
Department of Medicine, Division of Gastroenterology + Hepatology